http://www.streetinsider.com Latest StreetInsider.com News Articles en-us Copyright 2026, StreetInsider.com rss@streetinsider.com (SI RSS) rss@streetinsider.com (SI RSS) Mon, 24 Aug 2026 20:52:00 -0400 http://blogs.law.harvard.edu/tech/rss http://www.streetinsider.com/images/rss_logo.gif http://www.streetinsider.com 143 28 0 1 2 3 21 22 23 Saturday Sunday http://www.streetinsider.com/SEC+Filings/Form++4++++++++++Apollomics+Inc.+++++++++++For%3A+Aug+17++Filed+by%3A+Huang+Ya-Chi/26969577.html si-local-file:///var/storage/secattach/20260824/26969577.html http://www.streetinsider.com/SEC+Filings/Form++4++++++++++Apollomics+Inc.+++++++++++For%3A+Aug+17++Filed+by%3A+Huang+Ya-Chi/26969577.html Mon, 24 Aug 2026 20:52:00 -0400 APLM O.53171576 http://www.streetinsider.com/SEC+Filings/Form++4++++++++++Apollomics+Inc.+++++++++++For%3A+Aug+17++Filed+by%3A+Huang+Ya-Chi/26969577.html si-local-file:///var/storage/secattach/20260824/26969577.html http://www.streetinsider.com/SEC+Filings/Form++4++++++++++Apollomics+Inc.+++++++++++For%3A+Aug+17++Filed+by%3A+Huang+Ya-Chi/26969577.html Mon, 24 Aug 2026 20:52:00 -0400 APLM O.53171576 http://www.streetinsider.com/SEC+Filings/Form++D++++++++++Apollomics+Inc.++++++++++++++++++++++/26946753.html si-local-file:///var/storage/secattach/20260819/26946753.html http://www.streetinsider.com/SEC+Filings/Form++D++++++++++Apollomics+Inc.++++++++++++++++++++++/26946753.html Wed, 19 Aug 2026 06:04:00 -0400 APLM O.53171576 http://www.streetinsider.com/SEC+Filings/Form++D++++++++++Apollomics+Inc.++++++++++++++++++++++/26946753.html si-local-file:///var/storage/secattach/20260819/26946753.html http://www.streetinsider.com/SEC+Filings/Form++D++++++++++Apollomics+Inc.++++++++++++++++++++++/26946753.html Wed, 19 Aug 2026 06:04:00 -0400 APLM O.53171576 http://www.streetinsider.com/SEC+Filings/Form++4++++++++++Apollomics+Inc.+++++++++++For%3A+Aug+14++Filed+by%3A+Chen+Yi-Kuei/26939278.html si-local-file:///var/storage/secattach/20260817/26939278.html http://www.streetinsider.com/SEC+Filings/Form++4++++++++++Apollomics+Inc.+++++++++++For%3A+Aug+14++Filed+by%3A+Chen+Yi-Kuei/26939278.html Mon, 17 Aug 2026 19:32:00 -0400 APLM O.53171576 http://www.streetinsider.com/SEC+Filings/Form++4++++++++++Apollomics+Inc.+++++++++++For%3A+Aug+14++Filed+by%3A+Chen+Yi-Kuei/26939278.html si-local-file:///var/storage/secattach/20260817/26939278.html http://www.streetinsider.com/SEC+Filings/Form++4++++++++++Apollomics+Inc.+++++++++++For%3A+Aug+14++Filed+by%3A+Chen+Yi-Kuei/26939278.html Mon, 17 Aug 2026 19:32:00 -0400 APLM O.53171576 http://www.streetinsider.com/SEC+Filings/Form++4++++++++++Apollomics+Inc.+++++++++++For%3A+Aug+14++Filed+by%3A+LIN+PETER+KUAN-HOW/26939262.html si-local-file:///var/storage/secattach/20260817/26939262.html http://www.streetinsider.com/SEC+Filings/Form++4++++++++++Apollomics+Inc.+++++++++++For%3A+Aug+14++Filed+by%3A+LIN+PETER+KUAN-HOW/26939262.html Mon, 17 Aug 2026 19:23:00 -0400 APLM O.53171576 http://www.streetinsider.com/SEC+Filings/Form++4++++++++++Apollomics+Inc.+++++++++++For%3A+Aug+14++Filed+by%3A+LIN+PETER+KUAN-HOW/26939262.html si-local-file:///var/storage/secattach/20260817/26939262.html http://www.streetinsider.com/SEC+Filings/Form++4++++++++++Apollomics+Inc.+++++++++++For%3A+Aug+14++Filed+by%3A+LIN+PETER+KUAN-HOW/26939262.html Mon, 17 Aug 2026 19:23:00 -0400 APLM O.53171576 http://www.streetinsider.com/SEC+Filings/Form++4++++++++++Apollomics+Inc.+++++++++++For%3A+Aug+14++Filed+by%3A+Chen+Hung-Wen/26939245.html si-local-file:///var/storage/secattach/20260817/26939245.html http://www.streetinsider.com/SEC+Filings/Form++4++++++++++Apollomics+Inc.+++++++++++For%3A+Aug+14++Filed+by%3A+Chen+Hung-Wen/26939245.html Mon, 17 Aug 2026 19:14:00 -0400 APLM O.53171576 http://www.streetinsider.com/SEC+Filings/Form++4++++++++++Apollomics+Inc.+++++++++++For%3A+Aug+14++Filed+by%3A+Chen+Hung-Wen/26939245.html si-local-file:///var/storage/secattach/20260817/26939245.html http://www.streetinsider.com/SEC+Filings/Form++4++++++++++Apollomics+Inc.+++++++++++For%3A+Aug+14++Filed+by%3A+Chen+Hung-Wen/26939245.html Mon, 17 Aug 2026 19:14:00 -0400 APLM O.53171576 http://www.streetinsider.com/SEC+Filings/Form++SCHEDULE+13DA++Apollomics+Inc.++++++++++++++++++++++++Filed+by%3A+Chen+Hung-Wen/26937938.html si-local-file:///var/storage/secattach/20260817/26937938.html http://www.streetinsider.com/SEC+Filings/Form++SCHEDULE+13DA++Apollomics+Inc.++++++++++++++++++++++++Filed+by%3A+Chen+Hung-Wen/26937938.html Mon, 17 Aug 2026 16:05:00 -0400 APLM O.53171576 http://www.streetinsider.com/SEC+Filings/Form++SCHEDULE+13DA++Apollomics+Inc.++++++++++++++++++++++++Filed+by%3A+Chen+Hung-Wen/26937938.html si-local-file:///var/storage/secattach/20260817/26937938.html http://www.streetinsider.com/SEC+Filings/Form++SCHEDULE+13DA++Apollomics+Inc.++++++++++++++++++++++++Filed+by%3A+Chen+Hung-Wen/26937938.html Mon, 17 Aug 2026 16:05:00 -0400 APLM O.53171576 http://www.streetinsider.com/SEC+Filings/Form++SCHEDULE+13DA++Apollomics+Inc.++++++++++++++++++++++++Filed+by%3A+Chen+Yi-Kuei/26930926.html si-local-file:///var/storage/secattach/20260814/26930926.html http://www.streetinsider.com/SEC+Filings/Form++SCHEDULE+13DA++Apollomics+Inc.++++++++++++++++++++++++Filed+by%3A+Chen+Yi-Kuei/26930926.html Fri, 14 Aug 2026 16:22:00 -0400 APLM O.53171576 http://www.streetinsider.com/SEC+Filings/Form++SCHEDULE+13DA++Apollomics+Inc.++++++++++++++++++++++++Filed+by%3A+Chen+Yi-Kuei/26930926.html si-local-file:///var/storage/secattach/20260814/26930926.html http://www.streetinsider.com/SEC+Filings/Form++SCHEDULE+13DA++Apollomics+Inc.++++++++++++++++++++++++Filed+by%3A+Chen+Yi-Kuei/26930926.html Fri, 14 Aug 2026 16:22:00 -0400 APLM O.53171576 http://www.streetinsider.com/SEC+Filings/Form++6-K++++++++Apollomics+Inc.+++++++++++For%3A+Aug+11/26908143.html si-local-file:///var/storage/secattach/20260812/26908143.html http://www.streetinsider.com/SEC+Filings/Form++6-K++++++++Apollomics+Inc.+++++++++++For%3A+Aug+11/26908143.html Wed, 12 Aug 2026 06:01:00 -0400 APLM O.53171576 http://www.streetinsider.com/SEC+Filings/Form++6-K++++++++Apollomics+Inc.+++++++++++For%3A+Aug+11/26908143.html si-local-file:///var/storage/secattach/20260812/26908143.html http://www.streetinsider.com/SEC+Filings/Form++6-K++++++++Apollomics+Inc.+++++++++++For%3A+Aug+11/26908143.html Wed, 12 Aug 2026 06:01:00 -0400 APLM O.53171576 http://www.streetinsider.com/Equity+Offerings/Apollomics+announces+%2410M+private+placement+of+Class+A+shares/26906445.html <p>Apollomics Inc. (NASDAQ: APLM) has entered into definitive subscription agreements for a private placement of approximately $10.0 million, with closing expected on or about Aug. 14, 2026, subject to customary closing conditions.</p> <p>The transaction involves the issuance of up to 700,001 Class A ordinary shares at a par value of $0.01 per share, structured in two tranches. The first tranche consists of cash subscriptions for 533,334 Class A shares at $15.00 per share, generating approximately $8.0 million in gross cash proceeds before fees and expenses. The second tranche involves the automatic conversion of a $2.0 million unsecured convertible promissory note, dated http://www.streetinsider.com/Equity+Offerings/Apollomics+announces+%2410M+private+placement+of+Class+A+shares/26906445.html Tue, 11 Aug 2026 16:35:53 -0400 APLM APLMW O.53171576 http://www.streetinsider.com/Equity+Offerings/Apollomics+announces+%2410M+private+placement+of+Class+A+shares/26906445.html <p>Apollomics Inc. (NASDAQ: APLM) has entered into definitive subscription agreements for a private placement of approximately $10.0 million, with closing expected on or about Aug. 14, 2026, subject to customary closing conditions.</p> <p>The transaction involves the issuance of up to 700,001 Class A ordinary shares at a par value of $0.01 per share, structured in two tranches. The first tranche consists of cash subscriptions for 533,334 Class A shares at $15.00 per share, generating approximately $8.0 million in gross cash proceeds before fees and expenses. The second tranche involves the automatic conversion of a $2.0 million unsecured convertible promissory note, dated http://www.streetinsider.com/Equity+Offerings/Apollomics+announces+%2410M+private+placement+of+Class+A+shares/26906445.html Tue, 11 Aug 2026 16:35:53 -0400 APLM APLMW O.53171576 http://www.streetinsider.com/Equity+Offerings/Apollomics+announces+%2410M+private+placement+of+Class+A+shares/26906445.html <p>Apollomics Inc. (NASDAQ: APLM) has entered into definitive subscription agreements for a private placement of approximately $10.0 million, with closing expected on or about Aug. 14, 2026, subject to customary closing conditions.</p> <p>The transaction involves the issuance of up to 700,001 Class A ordinary shares at a par value of $0.01 per share, structured in two tranches. The first tranche consists of cash subscriptions for 533,334 Class A shares at $15.00 per share, generating approximately $8.0 million in gross cash proceeds before fees and expenses. The second tranche involves the automatic conversion of a $2.0 million unsecured convertible promissory note, dated http://www.streetinsider.com/Equity+Offerings/Apollomics+announces+%2410M+private+placement+of+Class+A+shares/26906445.html Tue, 11 Aug 2026 16:35:53 -0400 APLM APLMW O.53171576 http://www.streetinsider.com/Press+Releases/Apollomics+Announces+%2410+Million+Private+Placement+Transaction/26906444.html <p align="justify">FOSTER CITY, Calif., Aug. 11, 2026 (GLOBE NEWSWIRE) -- <a target="_blank" href="https://www.globenewswire.com/Tracker?data=jmbkzViEk1AksZYMi6QErkKAE8iZ4NMYKgh6XHTLovC9H1OXsPg1NMzA0-hkR6Iu_JYW4i4dBWaP46FE0BeX7MSPUEk8CQQqRGTz4mUshak=" rel="nofollow" target="_blank">Apollomics Inc.</a> (Nasdaq: <a target="_blank" href="https://www.globenewswire.com/Tracker?data=-35AxtOeT02VqEq0XdstCTy6Y_zK0SWfvGm-njpUiKFwamL_pTdXhDoO2goOLmsTXjVdL3AuhMtkZX-P9y2xIw8ANM03yaqJ74ZCmd5Wzv9_ufzYOrfLKeKOK1_XYLrS" rel="nofollow" target="_blank">APLM</a>) (“Apollomics” or the “Company”), a late-stage clinical biopharmaceutical company developing multiple oncology drug candidates to address difficult-to-treat and treatment-resistant cancers, today announced that it has entered into definitive subscription agreements (the “Subscription Agreements”) for a private placement transaction (the “Private Placement”) with certain accredited investors (the “Investors”), for an aggregate gross consideration of approximately $10.0 million. The Private Placement is expected to close on or about August 14, 2026, subject to the satisfaction of customary closing http://www.streetinsider.com/Press+Releases/Apollomics+Announces+%2410+Million+Private+Placement+Transaction/26906444.html Tue, 11 Aug 2026 16:35:00 -0400 APLM APLMW O.53171576 http://www.streetinsider.com/Press+Releases/Apollomics+Announces+%2410+Million+Private+Placement+Transaction/26906444.html <p align="justify">FOSTER CITY, Calif., Aug. 11, 2026 (GLOBE NEWSWIRE) -- <a target="_blank" href="https://www.globenewswire.com/Tracker?data=jmbkzViEk1AksZYMi6QErkKAE8iZ4NMYKgh6XHTLovC9H1OXsPg1NMzA0-hkR6Iu_JYW4i4dBWaP46FE0BeX7MSPUEk8CQQqRGTz4mUshak=" rel="nofollow" target="_blank">Apollomics Inc.</a> (Nasdaq: <a target="_blank" href="https://www.globenewswire.com/Tracker?data=-35AxtOeT02VqEq0XdstCTy6Y_zK0SWfvGm-njpUiKFwamL_pTdXhDoO2goOLmsTXjVdL3AuhMtkZX-P9y2xIw8ANM03yaqJ74ZCmd5Wzv9_ufzYOrfLKeKOK1_XYLrS" rel="nofollow" target="_blank">APLM</a>) (“Apollomics” or the “Company”), a late-stage clinical biopharmaceutical company developing multiple oncology drug candidates to address difficult-to-treat and treatment-resistant cancers, today announced that it has entered into definitive subscription agreements (the “Subscription Agreements”) for a private placement transaction (the “Private Placement”) with certain accredited investors (the “Investors”), for an aggregate gross consideration of approximately $10.0 million. The Private Placement is expected to close on or about August 14, 2026, subject to the satisfaction of customary closing http://www.streetinsider.com/Press+Releases/Apollomics+Announces+%2410+Million+Private+Placement+Transaction/26906444.html Tue, 11 Aug 2026 16:35:00 -0400 APLM APLMW O.53171576 http://www.streetinsider.com/Press+Releases/Apollomics+Announces+%2410+Million+Private+Placement+Transaction/26906444.html <p align="justify">FOSTER CITY, Calif., Aug. 11, 2026 (GLOBE NEWSWIRE) -- <a target="_blank" href="https://www.globenewswire.com/Tracker?data=jmbkzViEk1AksZYMi6QErkKAE8iZ4NMYKgh6XHTLovC9H1OXsPg1NMzA0-hkR6Iu_JYW4i4dBWaP46FE0BeX7MSPUEk8CQQqRGTz4mUshak=" rel="nofollow" target="_blank">Apollomics Inc.</a> (Nasdaq: <a target="_blank" href="https://www.globenewswire.com/Tracker?data=-35AxtOeT02VqEq0XdstCTy6Y_zK0SWfvGm-njpUiKFwamL_pTdXhDoO2goOLmsTXjVdL3AuhMtkZX-P9y2xIw8ANM03yaqJ74ZCmd5Wzv9_ufzYOrfLKeKOK1_XYLrS" rel="nofollow" target="_blank">APLM</a>) (“Apollomics” or the “Company”), a late-stage clinical biopharmaceutical company developing multiple oncology drug candidates to address difficult-to-treat and treatment-resistant cancers, today announced that it has entered into definitive subscription agreements (the “Subscription Agreements”) for a private placement transaction (the “Private Placement”) with certain accredited investors (the “Investors”), for an aggregate gross consideration of approximately $10.0 million. The Private Placement is expected to close on or about August 14, 2026, subject to the satisfaction of customary closing http://www.streetinsider.com/Press+Releases/Apollomics+Announces+%2410+Million+Private+Placement+Transaction/26906444.html Tue, 11 Aug 2026 16:35:00 -0400 APLM APLMW O.53171576 http://www.streetinsider.com/Globe+Newswire/Apollomics+Announces+%2410+Million+Private+Placement+Transaction/26906444.html <p align="justify">FOSTER CITY, Calif., Aug. 11, 2026 (GLOBE NEWSWIRE) -- <a target="_blank" href="https://www.globenewswire.com/Tracker?data=jmbkzViEk1AksZYMi6QErkKAE8iZ4NMYKgh6XHTLovC9H1OXsPg1NMzA0-hkR6Iu_JYW4i4dBWaP46FE0BeX7MSPUEk8CQQqRGTz4mUshak=" rel="nofollow" target="_blank">Apollomics Inc.</a> (Nasdaq: <a target="_blank" href="https://www.globenewswire.com/Tracker?data=-35AxtOeT02VqEq0XdstCTy6Y_zK0SWfvGm-njpUiKFwamL_pTdXhDoO2goOLmsTXjVdL3AuhMtkZX-P9y2xIw8ANM03yaqJ74ZCmd5Wzv9_ufzYOrfLKeKOK1_XYLrS" rel="nofollow" target="_blank">APLM</a>) (“Apollomics” or the “Company”), a late-stage clinical biopharmaceutical company developing multiple oncology drug candidates to address difficult-to-treat and treatment-resistant cancers, today announced that it has entered into definitive subscription agreements (the “Subscription Agreements”) for a private placement transaction (the “Private Placement”) with certain accredited investors (the “Investors”), for an aggregate gross consideration of approximately $10.0 million. The Private Placement is expected to close on or about August 14, 2026, subject to the satisfaction of customary closing http://www.streetinsider.com/Globe+Newswire/Apollomics+Announces+%2410+Million+Private+Placement+Transaction/26906444.html Tue, 11 Aug 2026 16:35:00 -0400 APLM APLMW O.53171576 http://www.streetinsider.com/Globe+Newswire/Apollomics+Announces+%2410+Million+Private+Placement+Transaction/26906444.html <p align="justify">FOSTER CITY, Calif., Aug. 11, 2026 (GLOBE NEWSWIRE) -- <a target="_blank" href="https://www.globenewswire.com/Tracker?data=jmbkzViEk1AksZYMi6QErkKAE8iZ4NMYKgh6XHTLovC9H1OXsPg1NMzA0-hkR6Iu_JYW4i4dBWaP46FE0BeX7MSPUEk8CQQqRGTz4mUshak=" rel="nofollow" target="_blank">Apollomics Inc.</a> (Nasdaq: <a target="_blank" href="https://www.globenewswire.com/Tracker?data=-35AxtOeT02VqEq0XdstCTy6Y_zK0SWfvGm-njpUiKFwamL_pTdXhDoO2goOLmsTXjVdL3AuhMtkZX-P9y2xIw8ANM03yaqJ74ZCmd5Wzv9_ufzYOrfLKeKOK1_XYLrS" rel="nofollow" target="_blank">APLM</a>) (“Apollomics” or the “Company”), a late-stage clinical biopharmaceutical company developing multiple oncology drug candidates to address difficult-to-treat and treatment-resistant cancers, today announced that it has entered into definitive subscription agreements (the “Subscription Agreements”) for a private placement transaction (the “Private Placement”) with certain accredited investors (the “Investors”), for an aggregate gross consideration of approximately $10.0 million. The Private Placement is expected to close on or about August 14, 2026, subject to the satisfaction of customary closing http://www.streetinsider.com/Globe+Newswire/Apollomics+Announces+%2410+Million+Private+Placement+Transaction/26906444.html Tue, 11 Aug 2026 16:35:00 -0400 APLM APLMW O.53171576 http://www.streetinsider.com/Globe+Newswire/Apollomics+Announces+%2410+Million+Private+Placement+Transaction/26906444.html <p align="justify">FOSTER CITY, Calif., Aug. 11, 2026 (GLOBE NEWSWIRE) -- <a target="_blank" href="https://www.globenewswire.com/Tracker?data=jmbkzViEk1AksZYMi6QErkKAE8iZ4NMYKgh6XHTLovC9H1OXsPg1NMzA0-hkR6Iu_JYW4i4dBWaP46FE0BeX7MSPUEk8CQQqRGTz4mUshak=" rel="nofollow" target="_blank">Apollomics Inc.</a> (Nasdaq: <a target="_blank" href="https://www.globenewswire.com/Tracker?data=-35AxtOeT02VqEq0XdstCTy6Y_zK0SWfvGm-njpUiKFwamL_pTdXhDoO2goOLmsTXjVdL3AuhMtkZX-P9y2xIw8ANM03yaqJ74ZCmd5Wzv9_ufzYOrfLKeKOK1_XYLrS" rel="nofollow" target="_blank">APLM</a>) (“Apollomics” or the “Company”), a late-stage clinical biopharmaceutical company developing multiple oncology drug candidates to address difficult-to-treat and treatment-resistant cancers, today announced that it has entered into definitive subscription agreements (the “Subscription Agreements”) for a private placement transaction (the “Private Placement”) with certain accredited investors (the “Investors”), for an aggregate gross consideration of approximately $10.0 million. The Private Placement is expected to close on or about August 14, 2026, subject to the satisfaction of customary closing http://www.streetinsider.com/Globe+Newswire/Apollomics+Announces+%2410+Million+Private+Placement+Transaction/26906444.html Tue, 11 Aug 2026 16:35:00 -0400 APLM APLMW O.53171576